Wound bed preparation and a brief history of TIME

International Wound Journal

Volumn 1, Issue 1, 2004, Pages 19-32

  Schultz, Gregory S ^a   Barillo, David J ^b   Mozingo, David W ^b   Chin, Gloria A ^b   Ayello, Elizabeth ^c   Dowsett, Carolina ^d   Falanga, Vince ^e   Harding, Keith ^f   Romanelli, Marco ^g   Sibbald, Gary ^h   Stacey, Michael ⁱ   Teot, Luc ^j   Vanscheidt, Wolfgang ^k  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d LONDON SOUTH BANK UNIVERSITY   (United Kingdom)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF PISA   (Italy)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ FREMANTLE HOSPITAL   (Australia)

^j UNIV MONTPELLIER   (France)

^k Rheintalklinik Astoria Privatkliniken   (Germany)

more..

Author keywords

Debridement; Growth factors; Infection; Inflammation; Moisture balance; Proteases; Wound bed preparation; Wound edge

Indexed keywords

BANDAGE; BIOFILM; CHRONIC DISEASE; DEBRIDEMENT; EPIDERMIS; HUMAN; INJURY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; WOUND HEALING;

BANDAGES; BIOFILMS; CHRONIC DISEASE; DEBRIDEMENT; EPIDERMIS; HUMANS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 23044443753     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481x.2004.00008.x     Document Type: Article

References (56)

1. AHCPR Panel for the Prediction and Prevention of Pressure Ulcers in Adults. Clinical practice guideline number 3. Pressure ulcers in adults: prediction and prevention. Rockville, MD: US Department of Health and Human Services, Agency for Health Care Policy and Research, 1992 (AHCPR Publication 92-0047).
2. The National Pressure Ulcer Advisory Panel. PUSH tool information and registration form (available from http://www.npuap.org/pushins.htm) 1998.
3. Sussman C, Bates-Jensen B, editors. Tools to measure wound healing. In: Wound care. A collaborative practice manual for physical therapists and nurses. Gaithersburg, MD: Aspen Publishers, 1998:103.
4. Falanga V. Wound bed preparation and the role of enzymes: a case for multiple actions of therapeutic agents. Wounds 2002;14:47-57.
5. Bucalo B, Eaglstein WH, Falanga V. Inhibition of cell proliferation by chronic wound fluid. Wound Repair Regen 1993;1:181-6.
6. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999;7:442-52.
7. Raffetto JD, Mendez MV, Marien BJ, Byers HR, Phillips TJ, Park HY, Menzoian JO. Changes in cellular motility and cytoskeletal actin in fibroblasts from patients with chronic venous insufficiency and in neonatal fibroblasts in the presence of chronic wound fluid. J Vasc Surg 2001;33:233-41.
8. Mendez MV, Raffetto JD, Phillips T, Menzoian JO, Park HY. The proliferative capacity of neonatal skin fibroblasts is reduced after exposure to venous ulcer wound fluid: a potential mechanism for senescence in venous ulcers. J Vasc Surg 1999;30: 734-43.
9. Falanga V. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen 2000;8:347-52.
10. Sibbald RG, Williamson D, Orsted HL, Campbell K, Keast D, Krasner D, Sibbald D. Preparing the wound bed - debridement, bacterial balance and moisture balance. Ostomy Wound Manage 2000; 46:14-35.
11. Inlow S, Orsted H, Sibbald RG. Best practices for the prevention, diagnosis, and treatment of diabetic foot ulcers. Ostomy Wound Manage 2000;46:55-68.
12. Dolynchuk K, Keast D, Campbell K, Houghton P, Orsted H, Sibbald G, Atkinson A. Best practices for the prevention and treatment of pressure ulcers. Ostomy Wound Manage 2000;46:38-52.
13. Ovington LG. Dressings and adjunctive therapies: AHCPR guidelines revisited. Ostomy Wound Manage 1999;45:94S-106S.
14. Harding K, editor. Wound bed preparation. International Congress and Symposium Series 250. Royal Society of Medicine Press Limited, Oxford, UK 2001.
15. Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, Romanelli M, Stacey MC, Teot L, Vanscheidt W. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen 2003;11:1-28.
16. Falanga V. The chronic wound: failure to heal. In: Falanga V, editor. Cutaneous wound healing. London: Martin Dunitz, 2001:155-64.
17. Hehenberger K, Heilborn JD, Brismar K, Hansson A. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of 1-lactate. Wound Repair Regen 1998;6:135-41.
18. Stanley AC, Park HY, Phillips TJ, Russakovsky V, Menzoian JO. Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. J Vasc Surg 1997;26: 999-1001.
19. Wright JB, Lam L, Buret AG, Olson MG, Burrell RE. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis and healing. Wound Rep Regen 2002;10:141-51.
20. Rogers AA, Harding KG, Chen WYJ. The epidermis at the edge of venous leg ulcers exhibits proliferative rather than differentiation markers and is associated with basement membrane disruption. Wound Repair Regen 2003;11:A15.
21. Cook H, Davies KJ, Harding KG, Thomas DW. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2 and MMP-2 activity. J Invest Dermatol 2000;115:225-33.
22. Mendez MV, Stanley A, Park HY, Shon K, Phillips T, Menzoian JO. Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. J Vasc Surg 1998;28:876-83.
23. Stanley A, Osler T. Senescence and the healing rates of venous ulcers. J Vasc Surg 2001;33:1206-11.
24. Agren MS, Steenfos HH, Dabelsteen S, Hansen JB, Dabelsteen E. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated form chronic leg ulcers is ulcer-dependent. J Invest Dermatol 1999;112: 463-9.
25. Hasan A, Murata H, Falabella A, Ochoa S, Zhou L, Bhadavias E, Falanga V. Dermal fibroblasts from venous ulcers are unresponsive to action of transforming growth factor-beta 1. J Dermatol Sci 1997; 16:59-66.
26. Van de Berg JS, Rudolph R, Hollan C, Haywood-Reid PL. Fibroblast senescence in pressure ulcers. Wound Repair Regen 1998;6:38-49.
27. Loots MA, Lamme EN, Mekkes JR, Bos JD, Middlekoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (noninsulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 1999;291:93-9.
28. Chin GA, Schultz G, Stacey M. Principles of wound bed preparation and their application to the treatment of chronic wounds. Primary Intention 2004;11:171-174.
29. Fowler E, van Rijswijk L. Using wound debridement to help achieve the goals of care. Ostomy Wound Manage 1995;41:23S-35S.
30. Cutting KF, Harding KG. Criteria for identifying wound infection. J Wound Care 1994;3:198-201.
31. Gardner SE, Frantz RA, Doebbeling BN. The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen 2001;9:178-86.
32. Sibbald RG, Orsted H, Schultz GS, Coutts P, Keast D. Preparing the wound bed 2003: focus on infection and inflammation. Ost Wound Mgt 2003;49:24-51.
33. Enoch S, Harding K. Wound bed preparation: the science behind the removal of barriers to healing. Wounds 2003;15:213-29.
34. Dow G, Browne A, Sibbald RG. Infections in chronic wounds. Ostomy Wound Manage 1999;45:23-40.
35. Robson MC, Lea CE, Daltong JB, Heggers JP. Quantitative bacteriology and delayed wound closure. Surg Forum 1968;19:501-2.
36. RobsonMC,Heggers JP. Surgical infection. II.The betahemolytic streptococcus. J Surg Res 1969;9: 289-92.
37. Thompson PD. What is the role of bacteria in chronic wound exudates? In: Cherry G, Harding KG, editors. Management of wound exudate. London: Churchill Communications, 1997:35-8.
38. Bucknall TE. The effect of local infection upon wound healing: an experimental study. Br J Surg 1980;67:851-55.
39. Schuchat A. Group B streptococcus. Lancet 1999; 353:51-6.
40. Davey ME, O'Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 2000;64:847-67.
41. Sundberg J, Meller R. A retrospective review of the use of cadexomer iodine in the treatment of chronic wounds. Wounds 1997;9:68-86.
42. Mertz PM, Oliveira-Gandia MF, Davis SC. The evaluation of a cadexomer iodine wound dressing on methicillin resistant Staphylococcus aureus (MRSA) in acute wounds. Dermatol Surg 1999;25:89-93.
43. Bishop JB, Phillips LG, Mustoe TA, van der Zee AJ, Wiersema L, Roach DE, Heggers JP et al. A prospective randomized evaluator-blinded trial of two potential wound healing agents of the treatment of venous stasis ulcers. J Vasc Surg 1992;16:251-7.
44. Kucan JO, Robson MC, Heggers JP, Ko F. Comparison of silver sulfadiazine, povidone-iodine and physiologic saline in the treatment of chronic pressure ulcers. J Am Geriatr Soc 1992;16:251-7.
45. Eaglstein WH, Mertz PM, Falanga V. Occlusive dressings. Am Fam Physician 1987;35:211-6.
46. Hinman CD, Maibach H. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963;200:377-8.
47. Winter GD. Formation of scab and the rate of epithelialisation of superficial wounds in the skin of the young domestic pig. Nature 1962;193:293-4.
48. Barnett A, Berkowitz RL, Mills R, Vistnes LM. Comparison of synthetic adhesive moisture vapour permeable and fine mesh gauze dressings for split-thickness skin graft donor sites. Am J Surg 1983;145:379-81.
49. Mandy SH. A new primary wound dressing made of polyethylene oxide gel. J Dermatol Surg Oncol 1983;9:153-5.
50. Falanga V. Apligraf treatment of venous ulcers and other chronic wounds. J Dermatol 1998;25:812-7.
51. Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003;26:1701-5.
52. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of becaplermin (recombinant human plateletderived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999;7:335-46.
53. Steed DL, Donohoe D, Webster MW, Lindsey L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 1996;183: 61-4.
54. Chin GA, Thigpin TG, Perrin KJ, Modawer LL, Schultz GS. Treatment of chronic ulcers in diabetic patients with a topical metalloproteinase inhibitor, doxycycline. Wounds 2003;15:315-23.
55. Bates-Jensen BM. Pressure ulcer assessment and documentation: the Pressure Sore Status Tool. In: Krasner D, Kane D, editors. Chronic wound care, 2nd edition. Wayne, PA: Health Management Publications, 1997:38.
56. Krasner D. Pressure ulcers: assessment, classification and management. In: Krasner D, Kane D, editors. Chronic wound care, 2nd edition. Wayne, PA: Health Management Publications, 1997:152-7.